- Profit after tax (consolidated)
- Rs 2,586.0 mn
- EPS
- Rs 8.29 -7.1%
- EPS a year earlier
- Rs 8.92
PSX Pharmaceuticals
AGP AGP Limited
Latest results: FY2025 · Dec 2025 Q2 FY2026 · Apr – Jun 2026
FY2025 revenue Rs 28.9 bn (+15.4%), profit Rs 3.7 bn (+39.9%). Dividend paid 8 years in a row.
Last close · 13 Nov 2026
Rs 156.37 ▼ 0.21 (-0.13%)
▼ 17.1% 1 year
- Market cap
- Rs 43.8 bn
- P/E
- 11.7×
- TTM to Jun 2026
- Sector 12.6× · lower
- P/B
- 2.92×
- Quarter to Jun 2026
- Sector 3.11× · lower
- Dividend yield
- 5.1%
- FY2025
- Payers 4.7% · higher
- ROE
- 25.9%
- FY2025
- Sector 21.7% · higher
- EPS
- Rs 13.35
- TTM to Jun 2026
- Book value / share
- Rs 53.57
- Quarter to Jun 2026
Fundamentals
AGP at a glance
Revenue · FY2025
Rs 28.9 bn
▲ 15.4% year on year
Profit attributable to shareholders · FY2025
Rs 3.7 bn
▲ 39.9% year on year
EPS – basic (Rs) · FY2025
Rs 13.34
▲ 39.9% year on year
Dividend per share (Rs) · FY2025
Rs 8.00
▲ 100.0% year on year
Net margin · FY2025
15.0%
+3.2 pts year on year
Debt to equity · FY2025
59.1%
-15.7 pts year on year
Price performance
AGP returns
Close Rs 156.37
13 Nov 2026
| Period | Return | Rs | vs KSE-100 |
|---|---|---|---|
| MTD Month to date | +5.6% −1.3 pts vs KSE | +8.25 | −1.3 pts KSE +6.9% |
| 3M 3 months | −17.0% −15.8 pts vs KSE | −32.04 | −15.8 pts KSE −1.2% |
| 6M 6 months | −13.3% −19.5 pts vs KSE | −23.94 | −19.5 pts KSE +6.2% |
| YTD Year to date | −23.0% −25.2 pts vs KSE | −46.78 | −25.2 pts KSE +2.2% |
| 1Y 1 year | −17.1% −27.8 pts vs KSE | −32.28 | −27.8 pts KSE +10.7% |
| Long term | |||
| 3Y 3 years | +151.4% +36.0% a year −63.2 pts vs KSE | +94.18 | −63.2 pts KSE +214.7% |
| 5Y 5 years | +54.6% +9.1% a year −234.2 pts vs KSE | +55.25 | −234.2 pts KSE +288.8% |
Price return from the last close before each period; the fiscal year ends 31 December, so year to date is also fiscal year to date. Dividends are not included.
AGP Limited in brief
AGP Limited (AGP) reported revenue of Rs 28.9 bn for FY2025 (Jan – Dec 2025), up 15.4% from FY2024.
Profit attributable to shareholders was Rs 3.7 bn (EPS Rs 13.34), up 39.9%, a net margin of 15.0%.
It declared a dividend of Rs 8.00 per share for FY2025 and has paid a dividend in each of the last 8 years.
Net debt stood at Rs 9.0 bn.
Return on equity was 25.9%.
Over the last five years revenue grew at a compound 33.0% a year.
At Rs 156.37 (close on 13 Nov 2026) the shares trade at 11.7× earnings (TTM to Jun 2026) and 2.92× book value, with a dividend yield of 5.1%.
Scorecard vs Pharmaceuticals
14 companies- Growth
- Strong
- 26.0%
- Profitability
- Strong
- 15.0%
- Financial health
- Weak
- 59.1%
- Valuation
- Above average
- 11.7×
- Dividends
- Strong
- 5.1%
Ratings place the company in its sector: growth (3-year revenue growth), profitability (net margin; return on equity for banks, insurers and finance companies), financial health (debt to equity, industrial companies), valuation (P/E at today's price) and dividends (yield at today's price). Five dots = top fifth. Rated within the sector when at least four companies report the figure, otherwise against all PSX companies of the same type (marked vs PSX). Information, not investment advice.
Corporate
AGP announcements & payouts
- Profit after tax (unconsolidated)
- Rs 1,190.5 mn
- EPS
- Rs 4.28 -52.0%
- EPS a year earlier
- Rs 8.92
- Profit after tax (consolidated)
- Rs 1,553.5 mn
- EPS
- Rs 5.21 -0.8%
- EPS a year earlier
- Rs 5.25
- Profit after tax (unconsolidated)
- Rs 875.8 mn
- EPS
- Rs 3.13 -40.4%
- EPS a year earlier
- Rs 5.25
Book closure 3 Sep – 4 Sep 2026 · Buy by Mon 31 Aug (est.) for the payout
Financial highlights
AGP financial results
| Rs bn | FY2025 Jan – Dec 2025 | FY2024 Jan – Dec 2024 | FY2023 Jan – Dec 2023 | FY2022 Jan – Dec 2022 | FY2021 Jan – Dec 2021 | FY2020 Jan – Dec 2020 | FY2019 Jan – Dec 2019 | FY2018 Jan – Dec 2018 | FY2017 Jan – Dec 2017 | FY2016 Jan – Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28.9 | 25.0 | 18.7 | 14.5 | 7.4 | 6.9 | 6.3 | 5.4 | 4.7 | 4.2 |
| Gross profit | 17.3 | 14.6 | 10.0 | 7.3 | 4.1 | 3.9 | 3.7 | 3.0 | 2.9 | 2.5 |
| Operating profit | 8.0 | 7.0 | 4.3 | 3.0 | 2.0 | 2.1 | 2.1 | 1.7 | 1.6 | 1.5 |
| Profit after tax | 4.3 | 3.0 | 1.8 | 1.7 | 1.6 | 1.6 | 1.4 | 1.2 | 1.2 | 1.1 |
| Profit attributable to shareholders | 3.7 | 2.7 | 1.6 | 1.6 | 1.6 | 1.6 | 1.4 | 1.2 | 1.2 | 1.1 |
| EPS – basic (Rs) Rs | 13.34 | 9.53 | 5.59 | 5.61 | 5.59 | 5.67 | 5.17 | 4.31 | 4.41 | 3.88 |
| Dividend per share (Rs) Rs | 8.00 | 4.00 | 2.50 | 2.00 | 2.50 | 2.00 | 3.25 | 1.25 | 0.00 | 0.00 |
| Total assets | 32.0 | 29.3 | 28.0 | 16.5 | 14.9 | 10.2 | 9.6 | 9.0 | 8.5 | 8.5 |
| Total equity | 17.1 | 14.6 | 12.4 | 11.1 | 10.2 | 8.2 | 7.5 | 6.4 | 5.5 | 4.3 |
| Total debt | 10.1 | 10.9 | 12.5 | 3.3 | 3.1 | 1.1 | 1.2 | 1.8 | 2.2 | 3.4 |
| Net cash from operating activities | 6.0 | 5.4 | 2.7 | 1.1 | 2.2 | 1.6 | 1.5 | 1.0 | 0.9 | 1.0 |
| Capital expenditure | (1.3) | (0.9) | (9.4) | (1.0) | (0.5) | (0.4) | (0.4) | (0.3) | (0.2) | (0.1) |
| Free cash flow (operating cash flow − capex) | 4.7 | 4.5 | (6.8) | 0.2 | 1.7 | 1.2 | 1.1 | 0.6 | 0.7 | 0.9 |
| Rs bn | TTM to Jun 2026 | Q2 FY2026 Apr – Jun 2026 | Q1 FY2026 Jan – Mar 2026 | Q4 FY2025 Oct – Dec 2025 | Q3 FY2025 Jul – Sep 2025 | Q2 FY2025 Apr – Jun 2025 | Q1 FY2025 Jan – Mar 2025 | Q4 FY2024 Oct – Dec 2024 | Q3 FY2024 Jul – Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27.7 | 4.7 | 6.9 | 8.5 | 7.6 | 5.6 | 7.2 | 7.4 | 6.0 |
| Gross profit | 16.7 | 2.9 | 4.0 | 5.2 | 4.7 | 3.3 | 4.1 | 4.7 | 3.5 |
| Operating profit | 7.5 | 1.0 | 1.8 | 2.5 | 2.2 | 1.3 | 2.1 | 2.6 | 1.8 |
| Profit after tax | 4.2 | 0.6 | 1.0 | 1.5 | 1.2 | 0.6 | 1.1 | 1.4 | 0.7 |
| Profit attributable to shareholders | 3.7 | 0.6 | 0.9 | 1.2 | 1.0 | 0.6 | 0.9 | 1.2 | 0.7 |
| EPS – basic (Rs) Rs | 13.35 | 2.15 | 3.06 | 4.42 | 3.72 | 2.20 | 3.04 | 4.27 | 2.47 |
| Dividend per share (Rs) Rs | 8.00 | 2.00 | 0.00 | 6.00 | 0.00 | 2.00 | 0.00 | 4.00 | 0.00 |
| Total assets | 32.5 | 32.5 | 32.6 | 32.0 | 32.1 | 30.7 | 30.7 | 29.3 | 29.3 |
| Total equity | 16.7 | 16.7 | 18.1 | 17.1 | 15.6 | 15.0 | 15.6 | 14.6 | 13.2 |
| Total debt | 12.3 | 12.3 | 10.2 | 10.0 | 11.2 | 11.3 | 10.6 | 10.9 | 12.3 |
| Net cash from operating activities | 3.5 | 0.0 | 0.1 | 2.1 | 1.3 | 1.3 | 1.3 | 2.5 | 1.4 |
| Capital expenditure | (1.0) | (0.3) | (0.2) | (0.3) | (0.2) | (0.5) | (0.3) | (0.3) | (0.2) |
| Free cash flow (operating cash flow − capex) | 2.6 | (0.3) | (0.1) | 1.8 | 1.1 | 0.8 | 0.9 | 2.2 | 1.2 |
Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets. Free cash flow and book value per share are calculated by Smart Money; TTM = the latest four quarters. Updated 26 Oct 2026.
AGP charts
Valuation
AGP valuation at today's price
- Price to earnings (P/E)
- 11.7×
- EPS Rs 13.35 (TTM to Jun 2026)
- Price to book (P/B)
- 2.92×
- Book value Rs 53.57 (Quarter to Jun 2026)
- Dividend yield
- 5.1%
- DPS Rs 8.00 (FY2025)
- Earnings yield
- 8.5%
- EPS ÷ price
At the closing price of Rs 156.37 on 13 Nov 2026. P/E and P/B are not shown when earnings or book value are negative.
Sector peers
AGP vs Pharmaceuticals companies
| Company | Market cap | P/E | P/B | Yield | ROE | 3-yr growth |
|---|---|---|---|---|---|---|
| AGP | Rs 43.8 bn | 11.7× | 2.92× | 5.1% | 25.9% | 26.0% |
| GLAXO | Rs 107.1 bn | 10.3× | 3.11× | 5.1% | 32.4% | 16.3% |
| ABOT | Rs 97.9 bn | 11.4× | 3.05× | 4.0% | 28.8% | 15.2% |
| HALEON | Rs 81.6 bn | 12.4× | 5.02× | 4.3% | 47.6% | 16.2% |
| HINOON | Rs 50.8 bn | 12.8× | 3.95× | 5.2% | 32.3% | 20.5% |
| HPL | Rs 38.5 bn | 10.3× | 4.50× | 6.0% | 38.6% | 18.6% |
| FEROZ | Rs 15.8 bn | 16.1× | 1.19× | 1.5% | 7.6% | 27.9% |
| CPHL | Rs 14.5 bn | 18.3× | 1.34× | 0.0% | 7.3% | 4.3% |
| MACTER | Rs 12.0 bn | 17.7× | 2.87× | 0.0% | 17.4% | 20.7% |
Analyses & signals 0
Win rate — · 0 closed signals · average return —
No analyses published for AGP yet.
AGP: frequently asked questions
What is AGP's EPS?
AGP Limited reported basic earnings per share of Rs 13.34 for FY2025 (Jan – Dec 2025). Over the trailing twelve months (TTM to Jun 2026) EPS was Rs 13.35.
What is AGP's P/E ratio?
At the closing price of Rs 156.37 on 13 Nov 2026, AGP trades at a P/E of 11.7× based on EPS of Rs 13.35 (TTM to Jun 2026).
Does AGP pay dividends?
Yes. AGP Limited declared a dividend of Rs 8.00 per share for FY2025. It has paid a dividend in each of the last 8 years. At Rs 156.37 that is a dividend yield of 5.1%.
What was AGP's revenue and profit in FY2025?
AGP Limited reported revenue of Rs 28.9 bn and profit attributable to shareholders of Rs 3.7 bn for FY2025 (Jan – Dec 2025).
What is AGP's book value per share?
AGP Limited's book value per share was Rs 55.24 at the end of FY2025. The shares trade at 2.92× book value.
How has AGP's share price performed?
AGP's share price is down 23.0% year to date (KSE-100: +2.2%), down 17.1% over one year (KSE-100: +10.7%) and up 54.6% over five years (KSE-100: +288.8%), as of 13 Nov 2026. These are price returns; dividends are not included.
Information only, not investment advice.